Erythema nodosum developed in a patient with advanced cutaneous melanoma treated with dabrafenib plus trametinib combination therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Erythema nodosum developed in a patient with advanced cutaneous melanoma treated with dabrafenib plus trametinib combination therapy

Published:2020-10-26 Issue:6 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Muto Yusuke¹,Fujimura Taku¹^ORCID,Kambayashi Yumi¹,Ohuchi Kentaro¹,Amagai Ryo¹,Okuma Takami¹,Furudate Sadanori¹,Hashimoto Akira¹,Aiba Setsuya¹

Affiliation:

1. Department of Dermatology Tohoku University Graduate School of Medicine Sendai Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14430

Reference9 articles.

1. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

2. Evidence for associations between Th1/Th17 "hybrid" phenotype and altered lipometabolism in very severe graves orbitopathy;Fang S;J Clin Endocrinol Metab,2020

3. Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literature

4. Interim analysis for post-marketing surveillance of dabrafenib and trametinib combination therapy in Japanese patients with unresectable and metastatic melanoma with BRAF V600 mutation

5. Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Panniculitis;Rook's Textbook of Dermatology;2024-03-19

2. Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy;European Journal of Dermatology;2023-04

3. Erythema nodosum and sarcoidosis;The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders;2021-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3